Description
Tirzepatide 30mg — Dual GLP-1/GIP Receptor Agonist Research Peptide
Tirzepatide is a synthetic dual GLP-1/GIP receptor agonist and FDA-approved active pharmaceutical ingredient, studied in metabolic and glycaemic research. Peptalix Labs supplies Tirzepatide 30mg at a verified purity of 99.82%, tested via a full QC panel by ILS Laboratories (ISO/IEC 17025 accredited, San Diego). GMP-sourced, lyophilised. Fast USA same-day shipping with delivery to Canada, Australia, the UK and Europe.
Certificate of Analysis
This product is independently tested by ILS Laboratories. COA #COA-2026-ZNN3K3 confirmed 99.82% purity with net peptide content of 31.76 mg (Lot 005-B-SM). The full panel includes a negative fentanyl screen, sterility testing (No Growth via PCR), and heavy metals analysis (all not detected). Independently verifiable at portal.ils-lab.com, Access Code EZBRQFS4.
Research Background
Tirzepatide research examines combined GLP-1 and GIP receptor agonism in metabolic regulation models. Frequently studied alongside Semaglutide (selective GLP-1) and Retatrutide (triple agonist) for comparative incretin-pathway research.
Product Specifications
- Product
- Tirzepatide 30mg
- Peptide Class
- Dual GLP-1/GIP Receptor Agonist
- Appearance
- Lyophilised, Good
- Purity
- 99.82% (Full QC Panel — HPLC)
- Net Peptide Content
- 31.76 mg per vial
- Lot Number
- 005-B-SM
- COA Number
- COA-2026-ZNN3K3
- Testing Lab
- ILS Laboratories, San Diego (ISO/IEC 17025 Accredited)
- Fentanyl Screen
- Not Detected (Pass)
- Sterility (PCR)
- No Growth (Pass)
- Heavy Metals
- Arsenic, Cadmium, Chromium, Mercury, Lead — All Not Detected (Pass)
- Storage
- Lyophilised: -20C. Reconstituted: 2-8C, use within 28 days
- Shipping
- USA same-day. Canada, Australia, UK, Europe
- Research Use
- In-vitro laboratory research only
Reconstitution Guide
Reconstitute using sterile bacteriostatic water. Inject slowly down the inner wall of the vial and gently swirl until dissolved. Never shake. Store reconstituted solution at 2-8C and use within 28 days.
Shipping
Same-day USA dispatch before daily cut-off Monday to Friday. International delivery to Canada, Australia, UK and Europe in 5-12 business days.
Related Weight Loss Research Compounds
- Semaglutide 20mg — GLP-1 Receptor Agonist
- Tirzepatide 60mg — Dual GLP-1/GIP Agonist
- Retatrutide 10mg — Triple Agonist Research Peptide
- Retatrutide 20mg — Triple Agonist Research Peptide
- AOD-9604 5mg — Fat-Metabolism Research Fragment
Scientific References
- Frias et al. — Tirzepatide dual GIP/GLP-1 agonism research (PubMed)
- NIH NLM — Tirzepatide dual incretin receptor research
- ClinicalTrials.gov — Search: Tirzepatide Research
Research Use Only. Not provided for clinical use, human consumption, or veterinary application outside of laboratory research settings.
Frequently Asked Questions
What is Tirzepatide peptide?
Tirzepatide is a synthetic dual GLP-1/GIP receptor agonist, an FDA-approved active pharmaceutical ingredient studied in metabolic and glycaemic research. Peptalix Labs supplies Tirzepatide 30mg at 99.82% purity, verified via a full QC panel by ILS Laboratories.
What purity is Peptalix Labs Tirzepatide 30mg?
Independently tested at 99.82% purity by ILS Laboratories (San Diego, ISO/IEC 17025 accredited) via a full QC panel. Net peptide content 31.76 mg per vial, Lot 005-B-SM, COA #COA-2026-ZNN3K3.
Is Tirzepatide FDA-approved?
Yes. Tirzepatide is an FDA-approved active pharmaceutical ingredient (marketed under brand names for clinical use). Peptalix Labs supplies research-grade Tirzepatide strictly for in-vitro laboratory research.
What makes Tirzepatide different from Semaglutide?
Tirzepatide is a dual GLP-1/GIP receptor agonist, while Semaglutide is selective for the GLP-1 receptor alone. The additional GIP agonism is studied for potential synergistic metabolic effects.
Which lab tested this product, and is the COA verifiable?
ILS Laboratories, an ISO/IEC 17025 accredited facility in San Diego, CA. The COA can be independently verified at portal.ils-lab.com using Access Code EZBRQFS4.
Does this COA include sterility and heavy metals testing?
Yes. The full QC panel includes heavy metals analysis (all Not Detected), sterility testing via PCR (No Growth), and a negative fentanyl screen.
How is Tirzepatide peptide stored?
Supplied as lyophilised powder. Store the sealed vial at -20C prior to reconstitution. Once reconstituted with bacteriostatic water, store at 2-8C and use within 28 days.
How do I reconstitute Tirzepatide 30mg?
Draw the desired volume of sterile bacteriostatic water into a fresh syringe and inject slowly down the inner wall of the vial. Gently swirl until fully dissolved. Never shake.
What research has been published on Tirzepatide?
Tirzepatide has been studied in dual-incretin-receptor research examining combined GLP-1 and GIP receptor agonism in metabolic and glycaemic regulation models.
Can I buy Tirzepatide 30mg peptide online in the USA?
Yes. Peptalix Labs offers Tirzepatide 30mg for purchase online for qualified USA researchers, with full QC panel COA verification.
Does Peptalix Labs ship Tirzepatide internationally?
Yes, to Canada, Australia, the United Kingdom and most of Europe, with tracked delivery in 5-12 business days.
Is Tirzepatide peptide legal to buy in the USA?
Yes, as a research chemical for qualified researchers conducting in-vitro laboratory studies. Sold strictly for research purposes, not for clinical or human use.
What is the appearance of Tirzepatide 30mg?
Lyophilised powder, rated ‘Good’ appearance on the ILS Laboratories COA.
Which lab verified Peptalix Labs Tirzepatide purity?
ILS Laboratories, San Diego, an ISO/IEC 17025 accredited facility. COA #COA-2026-ZNN3K3, Lab Director Dr. Greg Kalyuzhny.
What other GLP-1/GIP research peptides does Peptalix Labs offer?
Our weight-loss research category includes Semaglutide, both Tirzepatide dosages, Retatrutide (10mg, 20mg, 30mg), and AOD-9604 — all COA-verified and GMP-sourced.
